These studies indicate that c‐MYC significantly participates in the glutamine metabolism, supporting our finding that LINC01764 upregulates c‐MYC and promotes cell proliferation, migration, and attenuates 5‐FU resistance in CRC cells by regulating glutamine metabolism. Here, UCA1-AS1 is linked to colorectal carcinoma.